CLINICAL_TRIALS
trial_result
· 2012-05-04
Clinical Trial Update: Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting [Phase 1, Phase 2]
Summary
Phase 1 and Phase 2 trial results update on using palonosetron to prevent biochemotherapy-induced nausea and vomiting in patients with melanoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-05-04